Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2020 Volume 20 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

circKMT2D contributes to H2O2‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway

  • Authors:
    • Jun Zhang
    • Xubin Chou
    • Ming Zhuang
    • Chenlei Zhu
    • Yong Hu
    • Dong Cheng
    • Zhiwei Liu
  • View Affiliations / Copyright

    Affiliations: Department of Spine Surgery, The Third Affiliated Hospital of Soochow University, Changzhou 213001, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 65
    |
    Published online on: September 9, 2020
       https://doi.org/10.3892/etm.2020.9193
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Circular RNAs (circRNAs) have been demonstrated to be involved in osteosarcoma (OS) development; however, the underlying mechanism of circKMT2D in OS progression remains unclear. The present study aimed to elucidate how circKMT2D could affect hydrogen peroxide (H2O2)‑induced OS progression. H2O2 (100 µmol/l) was used to treat MG63 and U2OS cells. The cell viability, invasive ability, apoptosis and circKMT2D expression were detected using Cell Counting Kit‑8 assay, Transwell assay, flow cytometry and reverse transcription‑quantitative PCR, respectively. Furthermore, MG63 and U2OS cells transfected with circKMT2D short hairpin RNA and negative control were treated with H2O2, and circKMT2D expression and cell phenotype were determined. Dual‑luciferase reporter assay was conducted to determine the association between circKMT2D and miR‑210 expression level. Rescue experiments were conducted to examine the mechanisms through which circKMT2D and miR‑210 could affect H2O2‑treated MG63 cells. In addition, the effects of miR‑210 on the expression of the autophagy‑related proteins Beclin1 and p62 in H2O2‑treated MG63 cells were detected by western blotting. An autophagy inhibitor was used to treat the MG63 cells, and whether miR‑210 could affect the H2O2‑treated MG63 cell phenotype through autophagy was investigated. The results demonstrated that H2O2 treatment promoted cell apoptosis and decreased cell viability, invasive ability and circKMT2D expression in MG63 and U2OS cells. Furthermore, circKMT2D knockdown decreased the cell viability and invasive ability and enhanced the apoptosis of H2O2‑treated MG63 and U2OS cells. circKMT2D possessed binding sites for miR‑210 and inhibited miR‑210 expression. In H2O2‑treated MG63 cells, miR‑210 silencing partially reversed the circKMT2D knockdown‑induced cell viability inhibition and apoptosis promotion. In addition, miR‑210 elevated Beclin1 expression and decreased p62 expression in H2O2‑treated MG63 cells. The use of the autophagy inhibitor partially reversed the miR‑210 overexpression‑induced promotion of apoptosis and inhibition of the viability and invasive ability of H2O2‑treated MG63 cells. Taken together, these findings indicated that circKMT2D knockdown may contribute to the inhibition of H2O2‑attenuated OS progression via miR‑210/autophagy pathway.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Yang L, Ge D, Chen X, Qiu J, Yin Z, Zheng S and Jiang C: FOXP4-AS1 participates in the development and progression of osteosarcoma by downregulating LATS1 via binding to LSD1 and EZH2. Biochem Biophys Res Commun. 502:493–500. 2018.PubMed/NCBI View Article : Google Scholar

2 

Lin YH, Jewell BE, Gingold J, Lu L, Zhao R, Wang LL and Lee DF: Osteosarcoma: Molecular Pathogenesis and iPSC Modeling. Trends Mol Med. 23:737–755. 2017.PubMed/NCBI View Article : Google Scholar

3 

Bashur L and Zhou G: Cancer stem cells in osteosarcoma. Case Orthop J. 10:38–42. 2013.PubMed/NCBI

4 

Wang Z, Li B, Ren Y and Ye Z: T-cell-based immunotherapy for osteosarcoma: Challenges and opportunities. Front Immunol. 7(353)2016.PubMed/NCBI View Article : Google Scholar

5 

He C, Sun J, Liu C, Jiang Y and Hao Y: Elevated H3K27me3 levels sensitize osteosarcoma to cisplatin. Clin Epigenetics. 11(8)2019.PubMed/NCBI View Article : Google Scholar

6 

Fridovich I: Oxygen free radicals and tissue damage: Chairman's introduction. Ciba Found Symp. 1–4. 1978.PubMed/NCBI

7 

Dong K, Yang C, Yan Y, Wang P, Sun Y, Wang K, Lu T, Chen Q, Zhang Y, Xing J and Dong Y: Investigation of the intracellular oxidative stress amplification, safety and anti-tumor effect of a kind of novel redox-responsive micelle. J Mater Chem B. 6:1105–1117. 2018.PubMed/NCBI View Article : Google Scholar

8 

Hahn HJ, Kim KB, An IS, Ahn KJ and Han HJ: Protective effects of rosmarinic acid against hydrogen peroxideinduced cellular senescence and the inflammatory response in normal human dermal fibroblasts. Mol Med Rep. 16:9763–9769. 2017.PubMed/NCBI View Article : Google Scholar

9 

Wang Y, Wang W and Qiu E: Protection of oxidative stress induced apoptosis in osteosarcoma cells by dihydromyricetin through down-regulation of caspase activation and up-regulation of BcL-2. Saudi J Biol Sci. 24:837–842. 2017.PubMed/NCBI View Article : Google Scholar

10 

Pei W, Tao L, Zhang LW, Zhang S, Cao J, Jiao Y, Tong J and Nie J: Circular RNA profiles in mouse lung tissue induced by radon. Environ Health Prev Med. 22(36)2017.PubMed/NCBI View Article : Google Scholar

11 

Zhang HD, Jiang LH, Sun DW, Hou JC and Ji ZL: CircRNA: A novel type of biomarker for cancer. Breast Cancer. 25:1–7. 2018.PubMed/NCBI View Article : Google Scholar

12 

Barrett SP and Salzman J: Circular RNAs: Analysis, expression and potential functions. Development. 143:1838–1847. 2016.PubMed/NCBI View Article : Google Scholar

13 

Salmena L, Poliseno L, Tay Y, Kats L and Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell. 146:353–358. 2011.PubMed/NCBI View Article : Google Scholar

14 

Chen L, Zhang S, Wu J, Cui J, Zhong L, Zeng L and Ge S: circRNA_100290 plays a role in oral cancer by functioning as a sponge of the miR-29 family. Oncogene. 36:4551–4561. 2017.PubMed/NCBI View Article : Google Scholar

15 

Wu Z, Shi W and Jiang C: Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis. Biochem Biophys Res Commun. 502:465–471. 2018.PubMed/NCBI View Article : Google Scholar

16 

Huang L, Chen M, Pan J and Yu W: Circular RNA circNASP modulates the malignant behaviors in osteosarcoma via miR-1253/FOXF1 pathway. Biochem Biophys Res Commun. 500:511–517. 2018.PubMed/NCBI View Article : Google Scholar

17 

Li Z, Xuan W, Huang L, Chen N, Hou Z, Lu B, Wen C and Huang S: Claudin 10 acts as a novel biomarker for the prognosis of patients with ovarian cancer. Oncol Lett. 20:373–381. 2020.PubMed/NCBI View Article : Google Scholar

18 

Yang X, Shi L, Yi C, Yang Y, Chang L and Song D: MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. Am J Cancer Res. 7:1738–1753. 2017.PubMed/NCBI

19 

Liu S, Jiang T, Zhong Y and Yu Y: miR-210 inhibits cell migration and invasion by targeting the brain-derived neurotrophic factor in glioblastoma. J Cell Biochem: Feb 11, 2019 (Epub ahead of print).

20 

Tan W, Lim SG and Tan TM: Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1. World J Gastroenterol. 21:13030–13041. 2015.PubMed/NCBI View Article : Google Scholar

21 

Gulino R, Forte S, Parenti R, Memeo L and Gulisano M: MicroRNA and pediatric tumors: Future perspectives. Acta Histochem. 117:339–354. 2015.PubMed/NCBI View Article : Google Scholar

22 

Zhao XH, Xu ZR, Zhang Q and Yang YM: Simvastatin protects human osteosarcoma cells from oxidative stress-induced apoptosis through mitochondrial-mediated signaling. Mol Med Rep. 5:483–488. 2012.PubMed/NCBI View Article : Google Scholar

23 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar

24 

Zhang Y, Wang F, Li M, Yu Z, Qi R, Ding J, Zhang Z and Chen X: Self-stabilized hyaluronate nanogel for intracellular codelivery of doxorubicin and cisplatin to osteosarcoma. Adv Sci (Weinh). 5(1700821)2018.PubMed/NCBI View Article : Google Scholar

25 

Li S, Zhang T, Xu W, Ding J, Yin F, Xu J, Sun W, Wang H, Sun M, Cai Z and Hua Y: Sarcoma-targeting peptide-decorated polypeptide nanogel intracellularly delivers shikonin for upregulated osteosarcoma necroptosis and diminished pulmonary metastasis. Theranostics. 8:1361–1375. 2018.PubMed/NCBI View Article : Google Scholar

26 

Durfee RA, Mohammed M and Luu HH: Review of osteosarcoma and current management. Rheumatol Ther. 3:221–243. 2016.PubMed/NCBI View Article : Google Scholar

27 

Zhang Y, Cai L, Li D, Lao YH, Liu D, Li M, Ding J and Chen X: Tumor microenvironment-responsive hyaluronate-calcium carbonate hybrid nanoparticle enables effective chemotherapy for primary and advanced osteosarcomas. Nano Res. 11:4806–4822. 2018.

28 

Wu PF, Long LH, Zeng JH, Guan XL, Zhou J, Jin Y, Ni L, Wang F, Chen JG and Xie N: Protection of L-methionine against H2O2-induced oxidative damage in mitochondria. Food Chem Toxicol. 50:2729–2735. 2012.

29 

Glasauer A and Chandel NS: Targeting antioxidants for cancer therapy. Biochem Pharmacol. 92:90–101. 2014.PubMed/NCBI View Article : Google Scholar

30 

Lennicke C, Rahn J, Lichtenfels R, Wessjohann LA and Seliger B: Hydrogen peroxide-production, fate and role in redox signaling of tumor cells. Cell Commun Signal. 13(39)2015.PubMed/NCBI View Article : Google Scholar

31 

Park WH: Hydrogen peroxide inhibits the growth of lung cancer cells via the induction of cell death and G1phase arrest. Oncol Rep. 40:1787–1794. 2018.PubMed/NCBI View Article : Google Scholar

32 

Ogawa Y, Takahashi T, Kobayashi T, Kariya S, Nishioka A, Mizobuchi H, Noguchi M, Hamasato S, Tani T, Seguchi H, et al: Mechanism of hydrogen peroxide-induced apoptosis of the human osteosarcoma cell line HS-Os-1. Int J Mol Med. 12:459–463. 2003.PubMed/NCBI

33 

Zhang H, Wang G, Ding C, Liu P, Wang R, Ding W, Tong D, Wu D, Li C, Wei Q, et al: Increased circular RNA UBAP2 acts as a sponge of miR-143 to promote osteosarcoma progression. Oncotarget. 8:61687–61697. 2017.PubMed/NCBI View Article : Google Scholar

34 

Liu X, Zhong Y, Li J and Shan A: Circular RNA circ-NT5C2 acts as an oncogene in osteosarcoma proliferation and metastasis through targeting miR-448. Oncotarget. 8:114829–114838. 2017.PubMed/NCBI View Article : Google Scholar

35 

Liu H, Li P, Chen L, Jian C, Li Z and Yu A: MicroRNAs as a novel class of diagnostic biomarkers for the detection of osteosarcoma: A meta-analysis. OncoTargets Ther. 10:5229–5236. 2017.PubMed/NCBI View Article : Google Scholar

36 

Fujiwara T, Uotani K, Yoshida A, Morita T, Nezu Y, Kobayashi E, Yoshida A, Uehara T, Omori T, Sugiu K, et al: Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma. Oncotarget. 8:33375–33392. 2017.PubMed/NCBI View Article : Google Scholar

37 

Fan H, Lu S, Wang S and Zhang S: Identification of critical genes associated with human osteosarcoma metastasis based on integrated gene expression profiling. Mol Med Rep. 20:915–930. 2019.PubMed/NCBI View Article : Google Scholar

38 

Zhang Y, Yan J, Wang L, Dai H, Li N, Hu W and Cai H: HIF-1α promotes breast cancer cell MCF-7 proliferation and invasion through regulating miR-210. Cancer Biother Radiopharm. 32:297–301. 2017.PubMed/NCBI View Article : Google Scholar

39 

Wang Z, Yin B, Wang B, Ma Z, Liu W and Lv G: MicroRNA-210 promotes proliferation and invasion of peripheral nerve sheath tumor cells targeting EFNA3. Oncol Res. 21:145–154. 2013.PubMed/NCBI View Article : Google Scholar

40 

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R and Slaby O: MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma. Tumour Biol. 34:481–491. 2013.PubMed/NCBI View Article : Google Scholar

41 

Cai H, Lin L, Cai H, Tang M and Wang Z: Prognostic evaluation of microRNA-210 expression in pediatric osteosarcoma. Med Oncol. 30(499)2013.PubMed/NCBI View Article : Google Scholar

42 

Liu X, Zhang C, Wang C, Sun J, Wang D, Zhao Y and Xu X: miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1. Oncol Lett. 16:2229–2236. 2018.PubMed/NCBI View Article : Google Scholar

43 

Zhang H, Mai Q and Chen J: MicroRNA-210 is increased and it is required for dedifferentiation of osteosarcoma cell line. Cell Biol Int. 41:267–275. 2017.PubMed/NCBI View Article : Google Scholar

44 

Ebner P, Poetsch I, Deszcz L, Hoffmann T, Zuber J and Ikeda F: The IAP family member BRUCE regulates autophagosome-lysosome fusion. Nat Commun. 9(599)2018.PubMed/NCBI View Article : Google Scholar

45 

Ding WX, Ni HM, Gao W, Hou YF, Melan MA, Chen X, Stolz DB, Shao ZM and Yin XM: Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J Biol Chem. 282:4702–4710. 2007.PubMed/NCBI View Article : Google Scholar

46 

Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ and Choi KS: Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res. 67:6314–6324. 2007.PubMed/NCBI View Article : Google Scholar

47 

Terman A, Gustafsson B and Brunk UT: Autophagy, organelles and ageing. J Pathol. 211:134–143. 2007.PubMed/NCBI View Article : Google Scholar

48 

Li L, Li Y, Zhao J, Fan S, Wang L and Li X: CX-5461 induces autophagy and inhibits tumor growth via mammalian target of rapamycin-related signaling pathways in osteosarcoma. Onco Targets Ther. 9:5985–5997. 2016.PubMed/NCBI View Article : Google Scholar

49 

Ranjan A and Srivastava SK: Penfluridol suppresses pancreatic tumor growth by autophagy-mediated apoptosis. Sci Rep. 6(26165)2016.PubMed/NCBI View Article : Google Scholar

50 

Li C, Xu H, Chen X, Chen J, Li X, Qiao G, Tian Y, Yuan R, Su S, Liu X and Lin X: Aqueous extract of clove inhibits tumor growth by inducing autophagy through AMPK/ULK pathway. Phytother Res. 33:1794–1804. 2019.PubMed/NCBI View Article : Google Scholar

51 

Xu J, Wang H, Hu Y, Zhang YS, Wen L, Yin F, Wang Z, Zhang Y, Li S, Miao Y, et al: Inhibition of CaMKIIα activity enhances antitumor effect of fullerene C60 nanocrystals by suppression of autophagic degradation. Adv Sci (Weinh). 6(1801233)2019.PubMed/NCBI View Article : Google Scholar

52 

Zhou W, Yue C, Deng J, Hu R, Xu J, Feng L, Lan Q, Zhang W, Ji D, Wu J, et al: Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer. PLoS One. 8(e80338)2013.PubMed/NCBI View Article : Google Scholar

53 

Xu R, Liu S, Chen H and Lao L: MicroRNA-30a downregulation contributes to chemoresistance of osteosarcoma cells through activating Beclin-1-mediated autophagy. Oncol Rep. 35:1757–1763. 2016.PubMed/NCBI View Article : Google Scholar

54 

Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, et al: Autophagy suppresses tumorigenesis through elimination of p62. Cell. 137:1062–1075. 2009.PubMed/NCBI View Article : Google Scholar

55 

Lan SH, Wu SY, Zuchini R, Lin XZ, Su IJ, Tsai TF, Lin YJ, Wu CT and Liu HS: Autophagy suppresses tumorigenesis of hepatitis B virus-associated hepatocellular carcinoma through degradation of microRNA-224. Hepatology. 59:505–517. 2014.PubMed/NCBI View Article : Google Scholar

56 

Cheong H, Wu J, Gonzales LK, Guttentag SH, Thompson CB and Lindsten T: Analysis of a lung defect in autophagy-deficient mouse strains. Autophagy. 10:45–56. 2014.PubMed/NCBI View Article : Google Scholar

57 

Graziano AC, Cardile V, Avola R, Vicario N, Parenti C, Salvatorelli L, Magro G and Parenti R: Wilms' tumor gene 1 silencing inhibits proliferation of human osteosarcoma MG-63 cell line by cell cycle arrest and apoptosis activation. Oncotarget. 8:13917–13931. 2017.PubMed/NCBI View Article : Google Scholar

58 

Zhang J, Yu XH, Yan YG, Wang C and Wang WJ: PI3K/Akt signaling in osteosarcoma. Clin Chim Acta. 444:182–192. 2015.PubMed/NCBI View Article : Google Scholar

59 

Perry JA, Kiezun A, Tonzi P, Van Allen EM, Carter SL, Baca SC, Cowley GS, Bhatt AS, Rheinbay E, Pedamallu CS, et al: Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma. Proc Natl Acad Sci USA. 111:E5564–E5573. 2014.PubMed/NCBI View Article : Google Scholar

60 

Wang L, Tang B, Han H, Mao D, Chen J, Zeng Y and Xiong M: miR-155 affects osteosarcoma MG-63 cell autophagy induced by adriamycin through regulating PTEN-PI3K/AKT/mTOR signaling pathway. Cancer Biother Radiopharm. 33:32–38. 2018.PubMed/NCBI View Article : Google Scholar

61 

Yue Z, Guan X, Chao R, Huang C, Li D, Yang P, Liu S, Hasegawa T, Guo J and Li M: Diallyl disulfide induces apoptosis and autophagy in human osteosarcoma MG-63 cells through the PI3K/Akt/mTOR pathway. Molecules. 24(2665)2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang J, Chou X, Zhuang M, Zhu C, Hu Y, Cheng D and Liu Z: circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway. Exp Ther Med 20: 65, 2020.
APA
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., & Liu, Z. (2020). circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway. Experimental and Therapeutic Medicine, 20, 65. https://doi.org/10.3892/etm.2020.9193
MLA
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., Liu, Z."circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway". Experimental and Therapeutic Medicine 20.5 (2020): 65.
Chicago
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., Liu, Z."circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway". Experimental and Therapeutic Medicine 20, no. 5 (2020): 65. https://doi.org/10.3892/etm.2020.9193
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Chou X, Zhuang M, Zhu C, Hu Y, Cheng D and Liu Z: circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway. Exp Ther Med 20: 65, 2020.
APA
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., & Liu, Z. (2020). circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway. Experimental and Therapeutic Medicine, 20, 65. https://doi.org/10.3892/etm.2020.9193
MLA
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., Liu, Z."circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway". Experimental and Therapeutic Medicine 20.5 (2020): 65.
Chicago
Zhang, J., Chou, X., Zhuang, M., Zhu, C., Hu, Y., Cheng, D., Liu, Z."circKMT2D contributes to H<sub>2</sub>O<sub>2</sub>‑attenuated osteosarcoma progression via the miR‑210/autophagy pathway". Experimental and Therapeutic Medicine 20, no. 5 (2020): 65. https://doi.org/10.3892/etm.2020.9193
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team